Ghazaleh Tabatabai
Neurologist.Physician Scientist. Neurooncologist. Molecular Biology.
Early PhaseClinical Trials.
Full Professor&Managing Director.
Passionate about Music&Literature.
@unituebingen.bsky.social
@neurooncotue.bsky.social
- Reposted by Ghazaleh TabatabaiVery happy to had the opportunity to present our data at the DGN in Berlin. @ghtabatabai.bsky.social @hih-tuebingen.bsky.social @dgn-ev.bsky.social
- We are very happy to present our data at the DGN in Berlin! @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @dgn-ev.bsky.social
- Reposted by Ghazaleh TabatabaiWe are very happy to present our data at the DGN in Berlin! @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @dgn-ev.bsky.social
- Reposted by Ghazaleh TabatabaiWe had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions! Looking forward to Rome! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @nihalolcaydogan.bsky.social @hih-tuebingen.bsky.social
- Reposted by Ghazaleh Tabatabai#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration! Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours. #EANO #btsm
- Reposted by Ghazaleh TabatabaiNow Surender Surender on stage, presenting our data on CDK4/6 inhibition in experimental glioma! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hih-tuebingen.bsky.social
- And now it‘s Hannes Becker on stage, presenting our data at EANO2025 👍🏼🙌 @neurooncotue.bsky.social
- Just happening. Max Niyazi on stage at EANO 2025 👍🏼💡
- Happening now 🙌😀 iFIT Lunch & Learn with Lisa Sevenich! @hih-tuebingen.bsky.social @unituebingen.bsky.social @lisasevenich.bsky.social
- Reposted by Ghazaleh TabatabaiErfolge in der Wissenschaft müssen auch gefeiert werden – und das haben wir bei der Verleihung der Heinz Maier-Leibnitz-Preise 2025 getan. 10 DFG-geförderte Forscher*innen haben sich in ihrem jeweiligen Fach verdient gemacht und wurden nun von DFG-Generalsekretärin Heide Ahrens in Berlin gewürdigt.
- Reposted by Ghazaleh TabatabaiWissenschaft braucht verlässliche Infrastrukturen - viele davon liegen noch in den USA. Der WR-Vorsitzende @wickwolfgang.bsky.social fordert in der @faznet.bsky.social eine europäische Strategie für mehr Unabhängigkeit👉 www.faz.net/aktuell/wiss... #DigitaleSouveränität #Forschung #Infrastruktur
- Reposted by Ghazaleh Tabatabai(6/6) Wir freuen uns auf Eure Ideen, Energie und Unterstützung – live in Heidelberg oder digital! Euer Team von Wissenschaft für Demokratie – Wir für Dich e.V. #Demokratie #Wissenschaft #Zivilgesellschaft #PolitischeBildung #Wisskomm #FaktenStattFake #Heidelberg #HybridEvent #Mitmachen
- Reposted by Ghazaleh Tabatabai(5) 👉 Den Mitgliedsantrag findet Ihr hier: lnkd.in/d8DbYXwx 📃 Satzung & Gebührenordnung: lnkd.in/dRkerMCd 📩 Anmeldung bitte per E-Mail an: info@wissenschaftfuerdemokratie.de (Zugangsdaten für Zoom und Teilnahmevoraussetzungen folgen nach Anmeldung.)
- Reposted by Ghazaleh Tabatabai(1) 🎉 Einladung: Der Verein „Wissenschaft für Demokratie – Wir für Dich“ stellt sich vor! 🎉 Aus der zivilgesellschaftlichen Initiative „Aufstehen für Demokratie“ wurde mit der Gründung am 23.5.2025 ein gemeinnütziger Verein – nun laden wir Euch herzlich zur Auftaktveranstaltung ein.
- Reposted by Ghazaleh Tabatabai⏱️Clock is ticking! The European Association of Neuro-Oncology (#EANO) and @neuroonc.bsky.social are accepting applications for the Editor-in-Chief of Neuro-Oncology Advances (NOA). Learn more: bit.ly/4j9AqV7 👉Application deadline: May 31, 2025
- Reposted by Ghazaleh Tabatabai🧠 Recently published in Neuro-Oncology: Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes 🔗 doi.org/10.1093/neuo... #EANOessentials #NeuroOncology #Meningioma #CNS
- Reposted by Ghazaleh TabatabaiLive from #ASCO25 in Chicago: presentation of latest results on HER3-DXd efficacy and safety in patients with leptomeningeal metastatic disease of solid tumors - with simultaneous publication in Nature Medicine. Learn more: doi.org/10.1038/s415... #NeuroOncology
- Almost 25 year old T-shirt, reminds me of great experience at MGH/HMS 2000/2001, @harvard.edu - hard to see this institution under pressure now, and impressed by the integrity and resilience of Harvard leadership (more on LinkedIn) 🙌 #Harvard #AcademicFreedom #ScienceForDemocracy #ScienceMatters
- Reposted by Ghazaleh TabatabaiThis Easter, we extend our gratitude and admiration to our ICOM members and medical community for your relentless dedication to advancing medicine and transforming lives. We hope you’re able to take some time to spend with your loved ones and relax!
- Reposted by Ghazaleh Tabatabai🧠 A new article on the characteristics, outcomes, and prognostic factors of young patients with WHO grade 3 oligodendrogliomas (IDH-mutant and 1p/19q codeleted) can be found in Cancer. Full article👉 acsjournals.onlinelibrary.wiley.com/doi/10.1002/... #EANOessentials #NeuroOncology #Oligodendroglioma
- Reposted by Ghazaleh TabatabaiThis new report by several ICOM authors in JAMA Oncology highlights the importance of a role for #CytogeneticProfiling in the next iteration of #CNS WHO grading. Read the full report now: bit.ly/3EmWNb2 @gelarehzadeh.bsky.social @justinzwang.bsky.social
- Reposted by Ghazaleh Tabatabai🧬A recent study published in @jama.com explores the role of Chromosome 1p loss and 1q gain for improved grading of meningiomas.🔍 Learn more: jamanetwork.com/journals/jam... #EANOessentials #NeuroOncology #Meningioma #Neurosurgery
- Reposted by Ghazaleh TabatabaiThe upcoming #CNO meeting includes a session on #meningiomas from two of our wonderful #ICOM members @FarshadNassiri and Dr. Serge Makarenko. Read the full agenda here: bit.ly/4j3fDT6
- Reposted by Ghazaleh Tabatabai🙌 It's been a wonderful PhD Retreat at the HIH yesterday, with lots of time for exchange, poster sessions and the election of the new PhD representatives: Stefano Iavarone, Niloofar Mokhtari @estherkuehn.bsky.social & Surender Surender @ghtabatabai.bsky.social 🎉
- Freue mich wieder auf die neuen Erstsemester-Studierenden Humanmedizin, tolle Organisation von Fachschaft und Mentorenprogramm Medizin 😀😀🙌👏
- Reposted by Ghazaleh Tabatabai🤩 Attend the "Understanding theranostics" session at #NMN2025 and register here: www.nmn-society.org/registration/! #theranostics #btsm
- Reposted by Ghazaleh TabatabaiPeople packed the streets across the U.S. on Saturday to protest against President Trump, his administration's cutbacks, financial turmoil and more. nyti.ms/43GRvS7
- Reposted by Ghazaleh Tabatabai🙌 Celebrating Women in #NeuroOncology! On #InternationalWomensDay, we honor the contributions of researchers, clinicians, and healthcare professionals advancing the field. EANO is proud to support and empower women in science & medicine! 💜 #IWD2024 #WomenInScience #Neurosurgery #AHP #btsm
- Reposted by Ghazaleh Tabatabai🚀Abstract submission for #EANO2025 is open! Share your #NeuroOncology research at the 20th #EANO Meeting in Prague, Oct 16-19, 2025. We can't wait to see your contributions! 🗓️ Deadline: April 30, 2025, 23:59 CEST. 🔗 Details: www.eano.eu/eano2025/abs... #btsm #braintumor
- Reposted by Ghazaleh TabatabaiDGN-Kongress 2025: Jetzt mitgestalten und Vorschläge für das wissenschaftliche Programm und die interprofessionelle #Neurologie einreichen! 📅 Deadline: 31. März 2025. ➡️ dgn.org/dgn-kongress... #neuroscience #neuroskyence
- Reposted by Ghazaleh TabatabaiFor readers interested in cancer therapies, this Review in the March issue discusses therapeutic targeting of the metabolic dysfunction of CD8 T cells and natural killer cells in cancer www.nature.com/articles/s41... rdcu.be/ecsNM
- Tübingen 20 Feb 2025 #aufstehenfuerdemokratie
- Reposted by Ghazaleh Tabatabai📡 Listen to the @neuroonc.bsky.social podcast with @nathaliealbert.bsky.social on measurable disease with FET-PET vs. MRI in glioblastoma: soc-neuro-onc.libsyn.com/measurable-d...! @eanoassociation.bsky.social @eortc.bsky.social
- Tübingen 12 Feb 2025 Geschwister Scholl Platz Democracy needs facts Science needs Democracy. #aufstehenfuerdemokratie
- Tübingen, 12 Feb 2025 Geschwister-Scholl-Platz „Democracy needs facts. Science and Innovation need Democracy“ #aufstehenfuerdemokratie
- Reposted by Ghazaleh TabatabaiScience Podcast KEY TO MY RESEARCH: 🚀 Can we reprogram life? "The genome is like a code that controls life." — Prof. Dr. Hannes Link. In this Podcast episode: 🔹 Unlocking metabolism 🔹 Using CRISPR to rewrite DNA 🧬 🔹 Engineering bacteria to fix CO₂ 🌍 🎧 All episodes: uni-tuebingen.de/en/269679
- Reposted by Ghazaleh Tabatabai"Do Objects Party Alone?" - Professor Dorothee Kimmich discusses the curious life of objects in #ModernLiterature. What if things around us could speak or live? Her #research rethinks the boundary between nature and culture, material and spirit. 👉 uni-tuebingen.de/en/269679 #Podcast #CulturalTheory
- Reposted by Ghazaleh TabatabaiDid art save Homo Sapiens? Prof. Nicholas Conard shares how creativity gave us an edge in KEY TO MY RESEARCH. “Every group of human beings we know has art.” uni-tuebingen.de/exzellenzstr... #Podcast #Archaeology #HumanEvolution
- Reposted by Ghazaleh Tabatabai👍 Herzlich Willkommen auf dem Bluesky-Account der #unituebingen. Wir posten ab sofort hier und auf unseren anderen Kanälen, z.B. Instagram, Facebook, LinkedIn, Mastodon. Unsere Aktivitäten auf X haben wir beendet.
- Reposted by Ghazaleh TabatabaiWir begrüßen Prof. Dr. Daniela Berg, Direktorin der Klinik für Neurologie am UKSH, Campus Kiel, als neue Präsidentin der DGN! Welche Ziele sie sich gesetzt hat, erklärt sie hier: dgn.org/mediathek/vi... #neuroskyence #prävention #neurologie
- NEW publication from our Lab 🥳💫🥳Genome-wide CRISPR-Cas9 screens identify identify BCL family members as modulators of response to regorafenib in experimental glioma. @neurooncotue.bsky.social pubmed.ncbi.nlm.nih.gov/39756423/
- Reposted by Ghazaleh Tabatabai📢The Gliofocus Study is now open in the EU! Led by Dr. Mehdi Touat in Paris and Dr. Juan Manuel Sepulveda Sanchez in Madrid, this Phase 3 clinical trial compares niraparib to TMZ in nGBM. 68 EU medical centers are in the global Gliofocus Study network. 🔗Gliofocus.org
- Merry Christmas and very best wishes für 2025! @hih-tuebingen.bsky.social @unituebingen.bsky.social @neurooncotue.bsky.social
- Needless to say: It should read - for - and not - für -, apologies for this typing error 😌
- Reposted by Ghazaleh Tabatabai🧵Just in time for : New research from the Venkataramani lab @CellCellPress maps how brain tumor cells create extensive neural networks in glioblastoma. Check out our paper here: authors.elsevier.com/sd/article/S... @ekinreyhan.bsky.social @svenjaktetzlaff.bsky.social 1/15
- Just happening in Tübingen: Great talk by Prof Ulrich Dirnagl on Research Integrity 🙌💡👍🏼 @hih-tuebingen.bsky.social
- Reposted by Ghazaleh TabatabaiIn case some mentors may want to read this. #Nature #PhD #scisky #student #mentor Source: www.researchgate.net/publication/...
- Reposted by Ghazaleh TabatabaiWhat is the best time of the month to treat breast cancer? #Nature "Breast Cancer: Menstrual cycle may affect chemotherapy sensitivity" Open Access www.nature.com/articles/s41...
- Reposted by Ghazaleh Tabatabai🎯Tips For PhD students How to Write A Nature Abstract #MIT #Nature #PhD #Postdocs Read more mitcommlab.mit.edu/broad/commki...
- Reposted by Ghazaleh TabatabaiStanford Hematology has launched a physician scientist search! Research program can be lab-based and/or translational. facultypositions.stanford.edu/en-us/job/49...
